Clinical Trial Update: Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sorafenib tosylate in combination with chemotherapy, radiation, and surgery for high-risk soft tissue sarcoma (stages IIB–IV); study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Sorafenib tosylate (sorafenib tosylate)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Pleomorphic Rhabdomyosarcoma, Stage IIB Adult Soft Tissue Sarcoma AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2020-06-11